News and press

For the latest on the data investigation following the 2024 Cyberattack, please visit synnoviscyberupdate.co.uk.

For all related media queries, please contact:
Telephone : +44 (0) 20 3077 0549
Email: synnovisqueries@fticonsulting.com

Filter by:

24th May 2012

New strategies for detecting steroid metabolic disorders-paneling vs profiling

Angel O.K. Chan

21st May 2012

Inhibition of pro-protein convertase subtilisin kexin 9 [corrected] (PCSK-9) as a treatment for hyperlipidaemia.

Pro-protein [corrected] convertase subtilisin kexin (PCSK)-9 is a newly discovered protein involved in intracellular and extracellular regulation of low-density lipoprotein receptor (LDLR) expression.

Professor Anthony S. Wierzbicki, Timothy C Hardman, Adie Viljoen

18th May 2012

Lumping and splitting in cardiovascular risk.

The world is divided into 'lumpers' and 'splitters' i.e. those that aggregate data to yield the widest possible conclusions and those that seek to sub-divide groups into smaller more plausible subgroups.

Professor Anthony S. Wierzbicki

16th May 2012

Approaches to detection of adrenocortical carcinoma

Diaz-Cano SJ, Schulte KM

11th May 2012

Diagnosing HIV infection in patients presenting with glandular fever-like illness in primary care: are we missing primary HIV infection?

The aim of the study was to examine the prevalence of HIV infection in patients presenting in primary care with glandular fever (GF)-like illness.

DTS Hsu, M Ruf, Dr Siobhan O’Shea, S Costelloe, J Peck, CYW Tong

10th April 2012

Diagnosis and treatment of severe hypertriglyceridemia.

Severe hypertriglyceridemia is associated with acute pancreatitis and can be a manifestation of lipoprotein lipase (LPL) deficiency.

Viljoen A, Professor Anthony S. Wierzbicki

7th March 2012

The origin, global distribution, and functional impact of the human 8p23 inversion polymorphism.

Genomic inversions are an increasingly recognized source of genetic variation.

Maximilian P.A. Salm , Stuart D. Horswell, Claire E. Hutchison, Helen E. Speedy, Xia Yang, Liming Liang, Eric E. Schadt, William O. Cookson, Professor Anthony S. Wierzbicki, Rossi P. Naoumova, Carol C. Sh

1st March 2012

New lipid-lowering drugs: an update.

Lipid lowering is established as a proven intervention to reduce atherosclerosis and its complications.

Professor Anthony S. Wierzbicki, Hardman TC, Viljoen A

13th February 2012

Management strategies for acute proximal deep vein thrombosis: a Delphi consensus.

Deep vein thrombosis (DVT) is a leading cause of cardiovascular disease.

Patterson BO, Karthikesalingam A, Morgan R, Professor Beverley Hunt, Thompson MM, Holt PJ

7th February 2012

Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.

To examine the efficacy and tolerability of rosuvastatin 5 mg at daily and non-daily dosing regimens.

Claire Meek , Professor Anthony S. Wierzbicki, Christina Jewkes, Patrick J Twomey, Martin A Crook, Alan Jones, Adie Viljoen

Last updated: 23/09/2022

Search form

News and press

eMail alerts and news

Site details

Search form

News and press

Share this page

eMail alerts and news

Follow us

Site details